Original webinar presented Thursday, April 6, 2017

In this program, Dr. Fred Massoomi (PharmD, FASHP) will provide an overview of USP 800 existing regulations and standards, and provide recommendations to minimize risks to patients.

Since 1979, the evidence has evolved to show that the adverse effects of hazardous drugs noted during therapy differs to that of accidental occupational exposures to healthcare workers. Since occupational exposures are often unknown unless mitigated as an outward reaction like a rash, health care workers do not have the luxury of a means to minimize toxicities once exposed. The best option for individuals who manage hazardous drugs is best practice standards that minimize the upfront risk of exposure.

Fast-forward to July 1, 2018, and full compliance with USP’s newest Chapter 800, “Handling Hazardous Drugs in Healthcare Settings” is expected.  An enforceable chapter that mandates safety measures are put in place to protect healthcare providers. This is the first chapter within USP to cross pollinate into not only pharmacy practices but also into nursing practices.  This is also the only chapter with USP that describes and mandates controls from drug selection to disposal. And, this is a chapter that focuses on all formulations of drugs listed as hazardous drugs.

We hope that you can join us, as this is a quickly evolving facet of pharmacy practice. It is critical for our patients that we get this right.

To access presentation slides for download, use this link.

To listen to a recording of this webinar, use the link below.

Share this on Twitter: